2519. A Multi-national Phase 3, Randomized, Double-Blind, Active Comparator-Controlled Clinical Trial to Study the Safety, Tolerability, and Efficacy of Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Subjects with Hospital-Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia

BACKGROUND: Hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) are associated with high mortality rates. In these patients, there is an unmet need for effective antimicrobial therapy. This study enrolled participants mainly from China to support the reg...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Junjie, Wei, Feng, Xiang, Peng, Tang, Zhengang, Ding, Lianshu, Losada, Maria C, Iamboliyska, Zlatka, Zhu, Mingfen, Guo, Xiaodan, Du, Xiaoling, Chen, Chang, Chen, Luke Francis, Zhou, Min, Qu, Jieming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678407/
http://dx.doi.org/10.1093/ofid/ofad500.2137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678407/
http://dx.doi.org/10.1093/ofid/ofad500.2137

Ejemplares similares